Molecular simulation of the amyloid β-peptide Aβ-(1-40) of Alzheimer's disease

被引:13
|
作者
Mager, PP [1 ]
机构
[1] Univ Saxony, Res Grp Pharmacochem, Inst Pharmacol & Toxicol, Saxony, Germany
关键词
morbus Alzheimer; A beta peptide; molecular simulation; conformation transitions;
D O I
10.1080/08927029808024178
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
The amyloid A beta(1-40) peptide of Alzheimer's disease was chosen as model compound. This A beta peptide is an intrinsically soluble peptide; the C-terminal amino acids are less hydrophilic than the amino acids at the N-terminus, and the degree of hydrophilicity of the N-terminus depends strongly on the pH. The stronger local energy minimum of the random coil and a-helix means that the two conformations are more stable in solution. The relatively high-energy domain of the beta-sheet allows to surmount better the energy-barrier height during the formation of an activated complex with polarized ligands and macromolecules. It appears that interactions around the Phe19 and Phe20 area (hydrophobic core) of paired beta-sheets play a key role in formatting chi-like filaments. Energy calculation of a bi-and trimer supports the view that the aggregates are energetically stable oligomers which can easily be denatured, however. A perspective in drug research is to develop compounds that stabilize specifically the alpha-helix and random conformations of A beta(1-40), or inhibit the hydrophobic core.
引用
收藏
页码:201 / +
页数:24
相关论文
共 50 条
  • [1] Quaternary structure of a mature amyloid fibril from Alzheimer's aβ(1-40) peptide
    Sachse, Carsten
    Xu, Chen
    Wieligmann, Karin
    Diekmann, Stephan
    Grigorieff, Nikolaus
    Faendrich, Marcus
    JOURNAL OF MOLECULAR BIOLOGY, 2006, 362 (02) : 347 - 354
  • [2] Aqueous solution structural studies of 3-amyloid peptide - Residues 1-40 in the Alzheimer's disease
    Shao, H
    Zagorski, MG
    BIOPHYSICAL JOURNAL, 1998, 74 (02) : A299 - A299
  • [3] Interaction of Alzheimer beta-amyloid peptide(1-40) with lipid membranes
    Terzi, E
    Holzemann, G
    Seelig, J
    BIOCHEMISTRY, 1997, 36 (48) : 14845 - 14852
  • [4] Interactions of Amyloid β Peptide 1-40 and Cerebrosterol
    Kristofikova, Zdena
    Kriz, Zdenek
    Ripova, Daniela
    Koca, Jaroslav
    NEUROCHEMICAL RESEARCH, 2012, 37 (03) : 604 - 613
  • [5] How Cholesterol Constrains Glycolipid Conformation for Optimal Recognition of Alzheimer's β Amyloid Peptide (Aβ1-40)
    Yahi, Nouara
    Aulas, Anais
    Fantini, Jacques
    PLOS ONE, 2010, 5 (02):
  • [6] Amyloid-Beta (1-40) Peptide and Subclinical Cardiovascular Disease
    Stamatelopoulos, Kimon
    Pol, Christine J.
    Ayers, Colby
    Georgiopoulos, Georgios
    Gatsiou, Aikaterini
    Brilakis, Emmanouil S.
    Khera, Amit
    Drosatos, Konstantinos
    de Lemos, James A.
    Stellos, Konstantinos
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (09) : 1060 - 1061
  • [7] Calcium Ions Promote Formation of Amyloid β-Peptide (1-40) Oligomers Causally Implicated in Neuronal Toxicity of Alzheimer's Disease
    Itkin, Anna
    Dupres, Vincent
    Dufrene, Yves F.
    Bechinger, Burkhard
    Ruysschaert, Jean-Marie
    Raussens, Vincent
    PLOS ONE, 2011, 6 (03):
  • [8] Inhibitory effect of β-casein on the amyloid fibril formation of Aβ1-40 associated with Alzheimer's disease
    Ghahghaei, A.
    Shahraki, S.
    FEBS JOURNAL, 2015, 282 : 326 - 326
  • [9] Inhibitory Effect of β-Casein on the Amyloid Fibril Formation of Aβ1-40 Associated with Alzheimer's Disease
    Ghahghaei, Arezou
    Shahraki, Sima
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2016, 22 (01) : 23 - 29
  • [10] IRF-8 is Involved in Amyloid-β1-40 (Aβ1-40)-induced Microglial Activation: a New Implication in Alzheimer's Disease
    Zeng, Qinggan
    Man, Rongyong
    Luo, Yifeng
    Zeng, Ling
    Zhong, Yushi
    Lu, Bingxun
    Wang, Xiaofeng
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2017, 63 (02) : 159 - 164